N. Salazar

Instituto de Productos Lácteos de Asturias

Health Outcomes Studied

• Improved Gut Microbiota
• Increased Bifidobacteria Levels

Papers (5)

• 2021
  Role of Bifidobacteria on Infant Health10.3390/microorganisms9122415
• 2019
  Intestinal Immunomodulation and Shifts on the Gut Microbiota of BALB/c Mice Promoted by Two Bifidobacterium and Lactobacillus Strains Isolated from Human Samples10.1155/2019/2323540
• 2012Primary author
  Characterization of exopolysaccharides produced by Bifidobacterium longum NB667 and its cholate-resistant derivative strain IPLA B667dCo.10.1021/jf204034n
• 2011Primary author
  Safety and intestinal microbiota modulation by the exopolysaccharide-producing strains Bifidobacterium animalis IPLA R1 and Bifidobacterium longum IPLA E44 orally administered to Wistar rats.10.1016/j.ijfoodmicro.2010.10.016
• 2009Primary author
  Exopolysaccharides produced by Bifidobacterium longum IPLA E44 and Bifidobacterium animalis subsp. lactis IPLA R1 modify the composition and metabolic activity of human faecal microbiota in pH-controlled batch cultures.10.1016/j.ijfoodmicro.2009.08.017